Public Israeli biotechnology company is awarded a U.S. Patent granting the company exclusivity over manufacturing and commercialization of live bone grafts – we translated the Immediate Report to ISA/TASE and the international press release.
Securities
PREFERRED + EQUITY
NYSE listed REIT makes preparations for issuing up to US$250m of preferred stock on the Tel Aviv Stock Exchange – we translated the Description of the Securities Chapter from the Prospectus for consideration by the Israel Securities Authority and institutional investors.
CROSS + COLLATERAL
Publicly traded company gears up to refinance one of its material assets – we translated two separate Deeds of Trust for the lenders to evaluate cross-default potential between two series of the company’s TASE listed Debentures.
ISA/TASE + REPORTING
TASE listed U.S. real estate developer classifies a material property as inventory – we translated the Immediate Report and preceding correspondence with ISA staff clarifying the company’s position regarding adequate presentation in its financial statements.
CAPITAL + MARKETS
Renowned capital markets consultant advises international client on taking control of a clearing house – we translated the declarations filed in support of the Israel Securities Authority form: Application to Control a Stock Exchange and/or Clearing House.